Increlex and Depression - a phase IV clinical study of FDA data

Summary:

Depression is reported as a side effect among people who take Increlex (mecasermin recombinant), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Nutropin, and have Body height below normal.

The phase IV clinical study analyzes which people have Depression when taking Increlex. It is created by eHealthMe based on reports of 1,007 people who have side effects when taking Increlex from the FDA, and is updated regularly.

What is Increlex?

Increlex has active ingredients of mecasermin recombinant. eHealthMe is studying from 1,010 Increlex users. Check the latest studies of Increlex.

What is Depression?

Depression is found to be associated with 3,169 drugs and 4,124 conditions by eHealthMe. Check the latest studies of Depression.

On Jun, 19, 2026

1,007 people reported to have side effects when taking Increlex.
Among them, 16 people (1.59%) have Depression.

Among these 16 people:

How long have people been on Increlex when they have Depression? *

What is the gender of people who have Depression when taking Increlex? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Depression when taking Increlex? *

What are other drugs people take besides Increlex? *

What are other side effects people have besides Depression? *

Drowsiness: 4 people, 25.00%
Suicidal Ideation: 3 people, 18.75%
Stress And Anxiety: 3 people, 18.75%
Cardiac Disorder: 2 people, 12.50%
Muscle Atrophy (a decrease in the mass of the muscle): 2 people, 12.50%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 2 people, 12.50%
Fatigue (feeling of tiredness): 2 people, 12.50%
Therapeutic Response Decreased (less preventive response): 1 person, 6.25%
Echinococciasis (human infection by the immature (larval) form of tapeworm, echinococcus): 1 person, 6.25%
Anaemia (lack of blood): 1 person, 6.25%

What are the existing conditions these people have? *

Body Height Below Normal: 5 people, 31.25%
Growth Hormone Deficiency: 2 people, 12.50%
Failure To Thrive (inadequate weight gain and physical growth in children): 2 people, 12.50%
Stress And Anxiety: 1 person, 6.25%
Small For Dates Baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age): 1 person, 6.25%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.25%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Increlex and have Depression?

- Check whether Depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Increlex:

Increlex (1,010 reports)

Depression treatments and more:

Depression (652,136 reports)

Browse all side effects of Increlex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression:

Depression (3,169 drugs)

Browse all the conditions that are associated with Depression:

Depression (4,124 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mecasermin recombinant (the active ingredients of Increlex) and Increlex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.